Recalls and safety warnings for products, food, medicine and vehicles, with what to do if you have one.
On October 30, 2026, the U.S. Food and Drug Administration granted accelerated approval for Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) to treat adults with recurrent respiratory…
On October 29, 2026, the Food and Drug Administration announced a recall involving the StatStrip Glucose Hospital Meter System due to potential risks of assigning glucose results to the wrong patient. Nova Biomedical…
Vitality Works Inc. of Albuquerque, New Mexico, is recalling one lot of 365 Whole Foods Market Standardized + Full Spectrum Blend Ashwagandha Capsules due to potential contamination with Salmonella, according to the…
The Food and Drug Administration (FDA) is classifying the software-aided adjunctive diagnostic device for use by physicians on lesions suspicious for skin cancer into class II (special controls) effective October 30…
On October 30, 2026, the Food and Drug Administration (FDA) announced the classification of radiology software for referral of findings related to fibrotic lung disease into class II (special controls). This…
On October 30, 2026, the Food and Drug Administration (FDA) issued a final order classifying the spinal imaging system for neuraxial procedures into class II (special controls). The FDA determined that this…
The Food and Drug Administration (FDA) is classifying the over-the-counter device to assess risk of sleep apnea into class II (special controls) effective October 30, 2026. According to the FDA, this classification…
On October 30, 2026, the Consumer Product Safety Commission announced a direct final rule amending the mandatory safety regulation for automatic residential garage door operators. This amendment aligns the regulation…
On October 23, 2026, the White House signed a document further modifying the scope of products from Canada that are subject to additional duties. The changes were published in the Federal Register on October 30, 2026…
American Health Packaging is recalling Metoclopramide Tablets, USP, 5 mg, due to the presence of foreign tablets or capsules. The recall, classified as Class II, began on October 6, 2026, and is ongoing, affecting…
On September 29, 2026, Teva Pharmaceuticals USA, Inc initiated a recall of Metoclopramide Tablets, USP, 5 mg, due to the presence of foreign tablets or capsules. The recall, classified as Class II, may cause temporary…
On October 21, 2026, the Food and Drug Administration announced a Class I recall of medical devices from Instrumentation Laboratory. The recall, which began on September 3, 2026, affects the HemoslL AcuStar…
SLR Food Distribution Inc. of Hicksville, New York, is recalling Wise Wife Brand Ground Cinnamon due to potential contamination with elevated levels of lead, according to a release published on October 29, 2026. The…
On October 28, 2026, the Food and Drug Administration (FDA) announced that Medline has issued an Urgent Medical Device Field Safety Notice regarding the discontinuation and market exit of all Medline Brand beds and…
On October 26, 2026, the National Highway Traffic Safety Administration announced a notice of proposed rulemaking to amend Federal Motor Vehicle Safety Standard (FMVSS) No. 108, which covers lamps, reflective devices…
On October 21, 2026, PACCAR Incorporated announced a recall affecting 26,729 vehicles, including certain 2022-2023 Kenworth and Peterbilt models. The recall addresses a potential issue where remote fuel filter hoses…
On October 22, 2026, Chrysler (FCA US, LLC) announced a recall affecting certain 2026 Dodge Durango vehicles due to potential damage in the tail light wiring harness. The company stated that this issue may cause the…
On October 24, 2026, Imperio Distribution LLC announced a recall of approximately 946 pounds of ready-to-eat beef jerky products that were produced without the benefit of federal inspection. The U.S. Department of…
The U.S. Food and Drug Administration announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN) on October 22, 2026. This new program aims to advance the science, tools, and regulatory approaches…
On October 20, 2026, B. Braun notified customers of a recall for the Streamline Bloodline Set for Dialog+, citing a potentially high-risk device issue. The Food and Drug Administration (FDA) issued an Early Alert on…
Nothing matches. Try the search instead.
